Zelikson V, Gurumurthi A, Sawalha Y, Annunzio K, et al. Loncastuximab in high-risk and heavily pretreated relapsed / refractory diffuse large B-cell lymphoma: a real-world analysis from 21 US centers. Haematologica 2024 Nov 14:0. doi: 10.3324/haematol.2024.285977.
PMID: 39540227